Axillary Hyperhidrosis HDSM-Ax-7 Patient-Reported Outcomes for Sofpironium Topical Gel,12.45%: A Multicenter, Randomized, Controlled Double-Blind Study (NCT03836287). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 4, p. s588, 2025. DOI: 10.25251/yvdyat28. Disponível em: https://skin.dermsquared.com/skin/article/view/3533. Acesso em: 1 may. 2026.